Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 167
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00424463 | Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS) | ||
| NCT00542386 | A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia | ||
| NCT03645863 | Effects of Iron Supplements on the Pharmacokinetics of MT-6548 | ||
| NCT06994286 | The Purpose of This Study is to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects. | ||
| NCT01492686 | Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis | ||
| NCT02992925 | Phase 3 Study of BK1310 in Healthy Infants | ||
| NCT03402386 | Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan | ||
| NCT00246935 | Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08) | ||
| NCT05396235 | A Clinical Pharmacology Study of MT-3921 in Healthy Adult Males | ||
| NCT02354235 | Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin) | ||
| NCT00621296 | Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C | ||
| NCT01756716 | A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR | ||
| NCT00508924 | Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI) | ||
| NCT00780416 | Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C | ||
| NCT00781274 | Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based Therapy | ||
| NCT01878474 | Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 With Single, Escalating Doses in Healthy Subjects | ||
| NCT00059657 | Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease | ||
| NCT05198557 | A Study of MT-0551 in Patients With Systemic Sclerosis | ||
| NCT03570957 | A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients | ||
| NCT01753557 | Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C | ||
| NCT00805766 | Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD) | ||
| NCT00242294 | Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06) | ||
| NCT01596335 | Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease | ||
| NCT00415519 | Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification III | ||
| NCT03329196 | Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan | ||
| NCT02916706 | Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus | ||
| NCT00456326 | Heparin-Induced Thrombocytopenia Registry | ||
| NCT05658562 | A Study of MT-2111 in Patients With Relapsed/Refractory DLBCL | ||
| NCT00241631 | Enhancement of in-Vitro GC Function in Patients With COPD | ||
| NCT00772382 | Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia | ||
| NCT01879020 | Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in Healthy Subjects | ||
| NCT00416520 | A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia | ||
| NCT01072331 | Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus | ||
| NCT02327182 | Safety Study of MT-4666 in Subjects With Alzheimer's Disease | ||
| NCT00500682 | A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1) | ||
| NCT00537082 | Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS) | ||
| NCT01666327 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of MT-1303 in Subjects With Inflammatory Bowel Disease | ||
| NCT02220920 | Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus | ||
| NCT02517320 | Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy | ||
| NCT01625182 | Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients. | ||
| NCT01026194 | Efficacy and Safety Study of MP-513 in Combination With Thiazolidinedione in Patients With Type 2 Diabetes | ||
| NCT02310048 | Comparative Oral Bioavailability Study of MT-1303 | ||
| NCT00628212 | Efficacy and Safety Study of MP-513 in Patients With Type 2 Diabetes | ||
| NCT03245008 | Efficacy and Safety of MT-5547 in Patients With Osteoarthritis Accompanied by Moderate to Severe Pain | ||
| NCT03289208 | Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment | ||
| NCT00330681 | Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) | ||
| NCT01585155 | Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis | ||
| NCT04481750 | Study of Oral Edaravone in Healthy Adult Males | ||
| NCT00998881 | Monotherapy Study of MP-513 in Patients With Type 2 Diabetes | ||
| NCT04493281 | Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects |
